Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/05/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Market Cap	519K 453K 419K 392K 736K 48.97M 740K 4.97M 1.93M 24.1M 1.95M 1.91M 83.69M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.22M 17.8M 16.67M 31.26M 2.08B 31.45M 211M 81.86M 1.02B 82.76M 80.99M 3.56B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/05/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/04/24	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/11/23	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
05/10/23	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
02/10/23	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
30/09/23	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
15/08/23	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
02/08/23	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
10/07/23	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
10/07/23	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
15/06/23	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

11-18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
16/05/24	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
16/05/24	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
05/10/23	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
02/10/23	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-1.21%	-3.04%	+39.94%	+145.38%	980B
JOHNSON & JOHNSON	-2.48%	-5.18%	+51.52%	+39.07%	550B
ABBVIE INC.	-2.14%	-4.94%	+16.71%	+56.15%	382B
ROCHE HOLDING AG	+0.25%	-3.09%	+23.00%	+15.81%	317B
ASTRAZENECA PLC	+0.61%	-1.69%	+25.42%	+13.64%	270B
NOVARTIS AG	+0.22%	-3.10%	+24.25%	+30.21%	269B
NOVO NORDISK A/S	+4.59%	+1.98%	-40.02%	-45.89%	191B
AMGEN INC.	-1.19%	-4.95%	+16.56%	+47.00%	182B
GILEAD SCIENCES, INC.	-1.35%	-1.46%	+14.59%	+56.94%	154B
Average	-0.30%	-3.15%	+19.11%	+39.81%	366B
Weighted average by Cap.	-0.79%	-3.78%	+27.98%	+63.98%

Exactus Inc Stock OTC Bulletin Board

Stocks

US30066P1021

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

	2022	2023
Net sales	1.63M 1.42M 1.31M 1.23M 2.31M 154M 2.32M 15.59M 6.04M 75.56M 6.11M 5.98M 262M	2.38M 2.08M 1.93M 1.8M 3.38M 225M 3.4M 22.85M 8.85M 111M 8.95M 8.76M 385M
Net income	-9.14M -7.97M -7.38M -6.91M -12.96M -863M -13.04M -87.58M -33.94M -425M -34.32M -33.58M -1.47B	-8.02M -6.99M -6.47M -6.06M -11.36M -756M -11.43M -76.78M -29.76M -372M -30.09M -29.44M -1.29B
Net Debt	17.85M 15.57M 14.42M 13.5M 25.31M 1.68B 25.46M 171M 66.29M 829M 67.02M 65.58M 2.88B	21.53M 18.77M 17.39M 16.27M 30.52M 2.03B 30.71M 206M 79.93M 1B 80.82M 79.08M 3.47B